Home » Clinical Trials » Inherited retinal dystrophy » NCT06048185
NCT06048185

Long Term Follow-up for Participants Who Previously Received a Single Intravitreal Injection of MCO-010 Optogenetic Therapy in the STARLIGHT Study

Study Summary

The current study is a non-interventional long-term safety follow-up of the subjects who completed STARLIGHT, in accordance with FDA guidance on recipients of human gene therapy products.

Want to learn more about this trial?

Request More Info

Interventions

Gene Therapy Product-MCO-010BIOLOGICAL
The MCO-010 is an adeno-associated virus serotype 2-based vector carried multi-characteristic opsin (MCO) gene expression cassette

Study Locations

FacilityCityStateCountry
Nanocope Clnical SiteMiamiFloridaUnited States
Nanoscope Clinical SiteMcAllenTexasUnited States

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026